dexamethasone,lenalidomide,bortezomib
takeda
['mds', 'determination', 'aml,(-streamline),(-seamless),(-kamloops)', 'mmsm']
#asco22 #plenary4 dr. richardson presents "rvd asct and r maintenance to progression for newly diagnosed #mmsm: #determination trial mpfs: 67.6 v 46.2 m favor asct orr, mos no difference aml/mds with asct 
Fellow @MayoHemeOnc | @UConnIM| @UTexasSPH| @MDAndersonNews|@COVID19nCCC| #SoMeEditor @JCOCCI_ASCO| Co-Host @HemOncFellows https://t.co/dsiuV460lQ, Views my own